Skip to the page

Data / Drug companies / Solco Healthcare US, LLC

Solco Healthcare US, LLC: 259 products in the FDA NDC directory, labeler code 43547

Updated November 6, 2026. Source: US Food and Drug Administration, National Drug Code Directory (openFDA).

Solco Healthcare US, LLC (labeler code 43547) lists 259 products in the FDA National Drug Code Directory, covering 74 finished drugs by generic name. By type: 259 prescription drugs. Its main marketing category is generic drugs (ANDA). The newest product started marketing on August 17, 2026.

The request: Watch Solco Healthcare US, LLC (FDA labeler code 43547): each new product listing and each discontinued product. $10 of work on sign-up, no card.

SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.

Labeler code
43547
Products in commercial distribution
259
Packages
636
Finished drugs by generic name
74
Prescription products
259
Over the counter products
0
Controlled substance products
Schedule II 12, Schedule III 1, Schedule IV 8, Schedule V 8
Flagged as original packager
241 of 241 products that carry the flag
Started marketing in the last 12 months
7
Earliest marketing start
January 4, 2002
openFDA record search
api.fda.gov

Products by marketing category

Share of the company's products in commercial distribution.

Marketing categoryProductsShare
Generic drugs (ANDA)259100%

Products by type

TypeProductsShare
Prescription drugs259100%

Drugs it lists

Finished drugs by generic name, with how many companies list each.

DrugProductsCompanies listing it
Ropinirole hydrochloride149
Lisinopril1240
Aripiprazole1249
Levetiracetam1187
Quetiapine1130
Tadalafil954
Pregabalin854
Lisdexamfetamine dimesylate capsules71
Risperidone643
Ropinirole520
Valsartan and hydrochlorothiazide521
Donepezil hydrochloride434
Benazepril hydrochloride424
Nebivolol421
Temazepam428
Glycopyrrolate464
Quinapril410
Clonidine hydrochloride445
Enalapril maleate432
Paroxetine hydrochloride hemihydrate414
Captopril414
Valsartan438
Glimepiride332
Clonazepam336
Gabapentin391
Methylphenidate hydrochloride339
Potassium chloride extended-release313
Escitalopram334
Olmesartan medoxomil and hydrochlorothiazide317
Bumetanide342
Olmesartan medoxomil331
Pioglitazone317
Candesartan cilexetil and hydrochlorothiazide35
Hydrocortisone3171
Telmisartan329
Furosemide363
Losartan potassium and hydrochlorothiazide331
Doxycycline hyclate361
Nitroglycerin340
Bupropion hydrochloride367
Losartan potassium343
Irbesartan327
Duloxetine336
Telmisartan and hydrochlorothiazide39
Lisinopril and hydrochlorothiazide tablets312
Fenofibrate256
Metformin hydrochloride279
Potassium chloride284
Voriconazole234
Entecavir215
Bisoprolol fumarate225
Ciprofolxacin215
Dimethyl fumarate220
Febuxostat222
Fosinopril sodium26
Hydrochlorothiazide251
Methocarbamol267
Irbesartan and hydrochlorothiazide215
Esomeprazole magnesium277
Cyclobenzaprine hydrochloride261
Rocuronium bromide225
Amphetamine sulfate212
Phentermine hydrochloride126
Dicyclomine hydrochloride150
Roflumilast117
Paroxetine133
Pemetrexed19
Butalbital, acetaminophen and caffeine123
Fingolimod118
Acyclovir170
Fosinopirl sodium12
Ticagrelor132
Doxycycline163
Tranylcypromine13

Dosage forms

Dosage formProductsShare
Tablet13853.3%
Tablet, film coated4918.9%
Capsule2710.4%
Tablet, extended release135%
Injection72.7%
Capsule, delayed release72.7%
Tablet, coated62.3%
Tablet, film coated, extended release51.9%
Tablet, delayed release31.2%
Capsule, extended release20.8%
Injection, powder, for solution10.4%
Ointment10.4%

Pharmacologic classes

FDA established pharmacologic classes of its products.

Newest products

By marketing start date.

ProductProduct NDCDosage formMarketing categoryMarketing start
Hydrocortisone43547-894TabletGeneric drugs (ANDA)August 17, 2026
Hydrocortisone43547-893TabletGeneric drugs (ANDA)August 17, 2026
Hydrocortisone43547-892TabletGeneric drugs (ANDA)August 17, 2026
Gabapentin43547-481CapsuleGeneric drugs (ANDA)April 29, 2026
Gabapentin43547-480CapsuleGeneric drugs (ANDA)April 29, 2026
Gabapentin43547-479CapsuleGeneric drugs (ANDA)April 29, 2026
Doxycycline43547-590CapsuleGeneric drugs (ANDA)December 15, 2025
Nitroglycerin43547-987TabletGeneric drugs (ANDA)June 1, 2025
Nitroglycerin43547-986TabletGeneric drugs (ANDA)June 1, 2025
Nitroglycerin43547-985TabletGeneric drugs (ANDA)June 1, 2025
Ticagrelor43547-657Tablet, film coatedGeneric drugs (ANDA)April 1, 2025
Bumetanide43547-898TabletGeneric drugs (ANDA)March 1, 2025
Bumetanide43547-897TabletGeneric drugs (ANDA)March 1, 2025
Bumetanide43547-896TabletGeneric drugs (ANDA)March 1, 2025
Tadalafil43547-032TabletGeneric drugs (ANDA)November 27, 2024
Tadalafil43547-031TabletGeneric drugs (ANDA)November 27, 2024
Tadalafil43547-030TabletGeneric drugs (ANDA)November 27, 2024
Levetiracetam43547-880Tablet, film coatedGeneric drugs (ANDA)September 1, 2024
Pemetrexed43547-632Injection, powder, for solutionGeneric drugs (ANDA)July 1, 2024
Butalbital, acetaminophen and caffeine43547-686CapsuleGeneric drugs (ANDA)December 5, 2023
Ciprofloxacin43547-689TabletGeneric drugs (ANDA)October 1, 2023
Ciprofloxacin43547-688TabletGeneric drugs (ANDA)October 1, 2023
Lisdexamfetamine dimesylate43547-608CapsuleGeneric drugs (ANDA)August 26, 2023
Lisdexamfetamine dimesylate43547-607CapsuleGeneric drugs (ANDA)August 26, 2023
Lisdexamfetamine dimesylate43547-606CapsuleGeneric drugs (ANDA)August 26, 2023

CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.